Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare using FDA-approved bupivacaine (a numbing medicine),
along with the usual medications for post-operative pain control to using the usual
medications for postoperative pain control alone. The addition of bupivacaine to the surgical
wound site with the usual pain medications could better manage your pain immediately after
surgery and reduce the amount of opioid medications taken after surgery. This study will
allow the researchers to know whether this different approach is better, the same, or worse
than the usual approach.